Literature DB >> 6270000

Effects of cell source, mouse strain, and immunosuppressive treatment on production of virulent and attenuated murine cytomegalovirus.

M K Selgrade, J G Nedrud, A M Collier, D E Gardner.   

Abstract

Murine cytomegalovirus pools from various in vitro and in vivo sources were compared for virulence in suckling mice in an effort to identify the conditions which were necessary for the production of virulent and attenuated viruses. Virus passaged in tracheal ring and salivary gland organ cultures, where virus is produced primarily by epithelial cells, was even more attenuated than virus passaged in mouse embryo fibroblasts. The attenuation observed after passage in all three of these in vitro systems did not appear to be due to defective interfering particles. We also found that virus produced in vivo in salivary glands became attenuated with time after infection. Virus harvested from salivary glands 5 to 6 weeks after infection was highly attenuated compared with both salivary gland-passaged virus harvested 2 to 3 weeks after infection and tissue culture-passaged virus. The attenuation of salivary gland-passaged virus with time was reversed when animals were treated with cyclophosphamide before the virus was harvested. A comparison of virus pools harvested from susceptible and resistant mouse strains indicated that the mouse strain had little effect on the virulence of the virus produced. When the various sources of virus tested in this study were ranked in terms of the virulence of the virus produced, salivary glands in intact mice either 2 to 3 weeks after infection or after cyclophosphamide treatment produced the most virulent virus, followed by mouse embryo fibroblast cultures, tracheal ring and salivary gland organ cultures, and, finally, salivary glands in intact mice 5 to 6 weeks after infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270000      PMCID: PMC350788          DOI: 10.1128/iai.33.3.840-847.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Clinical and laboratory studies of live cytomegalovirus vaccine Ad-169.

Authors:  B J Neff; R E Weibel; E B Buynak; A A McLean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1979-01

2.  Infections with cytomegalovirus in bone marrow transplantation: report of a workshop.

Authors:  J S Pagano
Journal:  J Infect Dis       Date:  1975-07       Impact factor: 5.226

3.  Human cytomegalovirus immunization prospects.

Authors:  D N Medearis
Journal:  N Engl J Med       Date:  1977-06-02       Impact factor: 91.245

4.  Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus.

Authors:  S A Plotkin; J Farquhar; E Horberger
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

5.  Effect of immunization of mothers on cytomegalovirus infection in suckling mice.

Authors:  D N Medearis; S L Prokay
Journal:  Proc Soc Exp Biol Med       Date:  1978-04

6.  Cellular basis for susceptibility to mouse cytomegalovirus: evidence from tracheal organ culture.

Authors:  J G Nedrud; A M Collier; J S Pagano
Journal:  J Gen Virol       Date:  1979-12       Impact factor: 3.891

7.  Epidemiology of cytomegalovirus infection after transplantation and immunosuppression.

Authors:  M Fiala; J E Payne; T V Berne; T C Moore; W Henle; J Z Montgomerie; S N Chatterjee; L B Guze
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

8.  Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens.

Authors:  M K Selgrade; A Ahmed; K W Sell; M E Gershwin; A D Steinberg
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

9.  Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse.

Authors:  J E Chalmer; J S Mackenzie; N F Stanley
Journal:  J Gen Virol       Date:  1977-10       Impact factor: 3.891

10.  Virulence and attenuation of murine cytomegalovirus.

Authors:  J E Osborn; D L Walker
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

View more
  25 in total

1.  A little cooperation helps murine cytomegalovirus (MCMV) go a long way: MCMV co-infection rescues a chemokine salivary gland defect.

Authors:  Pranay Dogra; Mindy Miller-Kittrell; Elisabeth Pitt; Joseph W Jackson; Tom Masi; Courtney Copeland; Shuen Wu; William E Miller; Tim Sparer
Journal:  J Gen Virol       Date:  2016-09-13       Impact factor: 3.891

Review 2.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

3.  Remarkably Robust Antiviral Immune Response despite Combined Deficiency in Caspase-8 and RIPK3.

Authors:  Yanjun Feng; Devon Livingston-Rosanoff; Linda Roback; Aarthi Sundararajan; Samuel H Speck; Edward S Mocarski; Lisa P Daley-Bauer
Journal:  J Immunol       Date:  2018-09-07       Impact factor: 5.422

4.  Restoration of immunological responses by THF, a thymic hormone, in mice infected with murine cytomegalovirus (MCMV).

Authors:  E Katorza; M Pecht; R N Apte; D Benharroch; Y Burstein; N Trainin; B Rager-Zisman
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

5.  Mechanisms for virus-induced liver disease: tumor necrosis factor-mediated pathology independent of natural killer and T cells during murine cytomegalovirus infection.

Authors:  J S Orange; T P Salazar-Mather; S M Opal; C A Biron
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Evaluation of continuous cell lines in antiviral studies with murine cytomegalovirus.

Authors:  D F Smee; A Colletti; H A Alaghamandan; L B Allen
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus-augmented natural killer cell activity.

Authors:  M K Selgrade; M J Daniels; P C Hu; F J Miller; J A Graham
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

8.  Pathogenicity of murine cytomegalovirus for newborn mice: analysis with the attenuated mutants.

Authors:  K Ibusuki; K Kumura; Y Minamishima
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.

Authors:  J Neyts; H Sobis; R Snoeck; M Vandeputte; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

10.  Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells.

Authors:  Dai Wang; Qian-Chun Yu; Jörg Schröer; Eain Murphy; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.